Home › Lung Cancer › Vermont › Burlington
Lung Cancer clinical trials in Burlington, VT
4 studies for Lung Cancer are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The University of Vermont Medical Center Inc., Burlington
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Accelerated Pulmonary Rehabilitation in the Preoperative Period
Recruiting
- University of Vermont Medical Center, Burlington
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Burlington
- Heart Failure8 studies
- Acute Myeloid Leukemia7 studies
- Cancer (all types)6 studies
- COPD5 studies
- Breast Cancer5 studies
- Parkinson's Disease4 studies
- Non-Small Cell Lung Cancer4 studies
- Prostate Cancer4 studies
- Cystic Fibrosis4 studies
- Lung Diseases4 studies
- Leukemia4 studies
- Cardiovascular Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.